Form 4: Corcept Director Donates Shares, Direct Holdings Now Zero

Corcept Therapeutics Director Gillian Cannon donated 7,393 shares of common stock, resulting in zero direct beneficial ownership.

Summary

• Corcept Therapeutics Inc. Director Gillian Cannon reported a disposition of common stock.
• On September 10, 2025, Ms. Cannon donated 7,393 shares of Corcept common stock.
• The donation was made to a Fidelity Charitable Giving Account.
• Following this transaction, Ms. Cannon's direct beneficial ownership of Corcept common stock is reported as 0 shares.

Sentiment

Score: 5

Explanation: The filing reports a director's share donation, which is a personal philanthropic act rather than a sale for cash. While it results in zero direct beneficial ownership, it does not inherently reflect positively or negatively on the company's operational or financial performance.

Negatives

• The disposition of 7,393 shares by a director, particularly resulting in zero direct beneficial ownership, could be interpreted by some investors as a reduction in direct 'skin in the game'.

Industry Context

This is a routine insider transaction filing and does not provide broader industry context.

Stakeholder Impact

• Shareholders may note the director's disposition of shares and the resulting zero direct beneficial ownership.

Key Dates

Keywords

Corcept Therapeutics, CORT, Insider Transaction, Form 4, Share Donation, Director, Stock Disposition, Corporate Governance